Back to search

Poland· PL-100102105

Vitaminum A 2000 + D3 400 Hasco

A vitamin a and d in combination product containing retinoli palmitas + cholecalciferolum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC A11CB

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVitaminum A 2000 + D3 400 HascoATCA11CBREGISTER NO.PL-100102105PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Retinoli palmitas + cholecalciferolum is registered in 2 of 19 countries.

Countries holding a registration under ATC A11CB (vitamin a and d in combination), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Retinoli palmitas + cholecalciferolum · ATC A11CB

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Retinoli palmitas + Cholecalciferolum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
A11CB
ATC class
Vitamin A and D in combination
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990879212
  • gtin
    05909990879229

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Retinoli palmitas + cholecalciferolum in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All retinoli palmitas + cholecalciferolum products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/032a8aca-1472-41af-a925-7c305c73d59c
GET /v1/drugs/032a8aca-1472-41af-a925-7c305c73d59c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "2000 j.m. + 400 j.m",
  "packaging": "05909990879212 ¦ OTC ¦ 17613\n50 kaps.\n05909990879229 ¦ OTC ¦ Skasowane ¦ 17614\n50 kaps. w pojemniku",
  "substance": "Retinoli palmitas 2000 j.m. + Cholecalciferolum 400 j.m",
  "common_name": "Retinoli palmitas + Cholecalciferolum",
  "pl_product_id": "100102105",
  "pozwolenie_nr": "08792",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about retinoli palmitas + cholecalciferolum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.